Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antipsychotic medication
phenothiazine derivative |
| gptkbp:affiliatedWith |
first-generation antipsychotics
|
| gptkbp:ATCCode |
N05AA03
|
| gptkbp:CASNumber |
58-40-2
|
| gptkbp:chemicalFormula |
C17H20N2S
|
| gptkbp:contains_functional_group |
phenothiazine
dimethylamino group |
| gptkbp:discoveredBy |
1940s
|
| gptkbp:excretion |
gptkb:kidney
|
| https://www.w3.org/2000/01/rdf-schema#label |
promazine
|
| gptkbp:KEGGID |
D08413
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:meltingPoint |
112–113 °C
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
268.42 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL1201192
4926 DB00420 |
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous |
| gptkbp:sideEffect |
drowsiness
hypotension anticholinergic effects |
| gptkbp:synonym |
Sparine
|
| gptkbp:UNII |
UQT9G45D1P
|
| gptkbp:usedFor |
sedation
treatment of psychosis |
| gptkbp:bfsParent |
gptkb:acepromazine
|
| gptkbp:bfsLayer |
6
|